<<>>>
TitleUrlVersionPublisher
Lab Result (Cryptococcosis)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.40216
Test Method EIA IgMhttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.31421
Death Reporting Message Type (NCHS)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.74441
Fetus Weight (NCHS)http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.1512
Weakness (CDS - EHR)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.72581
Lab Result (Syphilis)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.40974
Antibiotic Received (RIBD)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.76932
Cleft Lip without Cleft Palate (NCHS)http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.601
Signs Symptoms (Zika)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.74591
Birthplace Setting (NCHS)http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.1841
Exposure Location (Brucellosis)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.80091
Message Structure (IIS)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.33762
Universal ID Type (HL7)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.10551
Cholera Signs Symptoms (FDD)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.30771
Lab Result (Rubella)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.31323
Emergency Severity Index - Acuityhttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.77761
Evaluation Status Reason (IIS)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.78311
Industry (SIC)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.9451
Public TransportationType (Anthrax)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.79921
NAACCR TNM Clinical Stage Descriptorhttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.101
Vibrio Cholera Biotype (FDD)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.76451
Volume Unitshttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.10532
Group B Streptococcus (NCHS)http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.1664
Countermeasure Encounter Typehttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.9891
PHIN Questions (Pediatric Flu)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.32781
Vibrio Species (FDD)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.76435
Zika-affected areashttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.74579
Provider Role Value Sethttp://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.4.21
Medication Received (VZ)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.31473
Body Site (FDD)http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.31171